Jinming Yu

机构：Shandong University, Guangxi University of Finance and Economics, Shandong First Medical University

发表论文 75 篇 · 总被引 3732 次 · h-index 22

代表论文

• The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy (2019 · Cancer Biology and Medicine · 被引 191)
• Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors (2022 · Frontiers in Oncology · 被引 48)
• From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape (2024 · Frontiers in Immunology · 被引 39)
• Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET/CT and overall survival in glioma patients (2019 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 39)
• High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma (2019 · Oncology Letters · 被引 21)
• Early detection of radiation-induced myocardial damage by [18F]AlF-NOTA-FAPI-04 PET/CT imaging (2022 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 20)